Critical Issues in Melanoma Follow-up and Treatment, Safety of Patients and Communication with Healthcare Professionals During Covid-19 Pandemic in Romania

Author(s) :

Violeta Astratinei1,2, Andreea Strambu-Dima1, Bettina Ryll2

1 Romanian Melanoma Association, Bucharest, Romania

2  Melanoma Patient Network Europe, Uppsala, Sweden

Corresponding author: Violeta Astratinei, Email:

Published: Journal of Medical and Radiation Oncology 1 (2021) 15-33, , , - DOI: 10.53011/JMRO.2021.01.02

Open Access

Full text


March 22, 2021 0 Comments

– a perspective of the Romanian Melanoma Association



Background: The Covid-19 pandemic has significantly impacted cancer care worldwide. The aim of this study was to capture the impact of Covid-19 on melanoma patients during the national state of emergency,

Material and methods: We sent a survey to the members of the Romanian Melanoma patient community between April – May 2020.

Results: We received feedback from 108 patients. Forty percent of the respondents experienced difficulties in accessing healthcare services, while 56% found it difficult or impossible to speak with their physician. With regard to feeling safe in healthcare facilities, 60% of patients felt safe in the private sector, versus 48% in public hospitals. Over half of the respondents delayed investigations such as dermoscopy, imaging, and laboratory tests by their own initiative, while a third saw investigation delayed upon their physician’s initiative. We found no significant delays in the administration of systemic therapies for advanced disease. While e-prescriptions for melanoma treatments were not communicated and implemented consistently, we noted an increased interest in telemedicine and social media networks by physicians. Spontaneous patient reports collected in the same period further show the lack of access to melanoma diagnostic surgery, insufficient management of side effects of different treatments, difficulties in obtaining pain medication, alterations in the administration schemes of both immunotherapies and target therapies, and cumbersome access to Covid-19 testing.

Conclusions: Our results provide a melanoma-specific perspective on the impact of Covid-19 on patients that is unexpectedly nuanced with regards to patient subpopulations and captures differences in impact between systemic treatment and other interventions. In addition, this proof-of-concept study demonstrates the ability of virtual patient communities to sensitively detect and report issues in health care provision, offering the opportunity for timely intervention. Based on our findings, we formulate a set of recommendations on how to save-guard melanoma care during the pandemic, some of which we believe to be generalizable to other patient communities.

Notify of
Inline Feedbacks
View all comments